Radiation Dermatitis Market: Introduction
According to the report, the global radiation dermatitis market was valued at ~US$ 400 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. The International Agency for Research on Cancer (IARC) states that the number of new cancer cases is likely to rise to 19.3 million, with 10 million cancer deaths in 2020. This indicates one in 5 people develop cancer during their lifetime, and one in 8 men and one in 11 women succumb to the disease. According to statistics presented by the American Society for Radiation Oncology, nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, whereas 85% of the total patient base experience severe to moderate radiation dermatitis that requires intensive treatment. This is expected to propel the global radiation dermatitis market.
Asia Pacific dominated the global radiation dermatitis market in 2019 and the trend is anticipated to continue during the forecast period. The rise in population suffering from cancer in Asia Pacific has increased the number of patients opting for radiation therapy. Hence, the usage of radiation dermatitis treatment products is expected to increase during the forecast period. Asia Pacific is likely to be a highly lucrative market for radiation dermatitis treatment from 2020 to 2030. The market in the region is projected to expand at a high CAGR during the forecast period.
Rise in Prevalence of Cancer to Drive Market
According to the WHO, cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women. The rate of certain types of cancer such as breast and head & neck is projected to increase in the near future. This can be attributed to faulty lifestyle factors such as obesity for breast cancer and smoking for head & neck cancers. Moreover, cancers mentioned above are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall rise in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the global radiation dermatitis market.
Topical Agents to Dominate Global Market
In terms of product, the global radiation dermatitis market has been classified into oral medication, topical, and dressings. The topical segment dominated the global radiation dermatitis market in 2019 and the trend is projected to continue during the forecast period. The growth of the segment can be attributed to the fact that topical agents are the most prescribed products in the radiation dermatitis treatment market, especially hydrophilic creams and corticosteroids. Hydrophilic creams are extensively used across the globe, as these provide hydration and soothing relief from itching, and other symptoms of radiation dermatitis.
Retail Pharmacies to be Major Distribution Channel
Based on distribution channel, the global radiation dermatitis market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the global radiation dermatitis market and the trend is anticipated to continue during the forecast period. Radiation dermatitis can develop either during or even several months after radiation therapy. Hence, a retail pharmacy is likely to be driven by patients who are referred to purchase particular products by peer recommendation. Additionally, it is driven by proximity to local area and familiarity of use by loyal customers.
Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.
Global Radiation Dermatitis Market: Segmentation
- Radiation Dermatitis Market, by Product
- Oral Medication
- Oral Analgesics & Antibiotics
- Hydrophilic Creams
- Topical Antibiotics
- No Sting Barrier film
- Honey Impregnated Gauze
- Silicone Coated Dressing
- Oral Medication
- Radiation Dermatitis Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Radiation Dermatitis Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- North America
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC